CONDUIT PHARMACEUTICAL
0.0991
27-November-24 15:45:00
15 minutes delayed
Stocks
+0.0056
+5.99%
Today's range
0.0893 - 0.1057
ISIN
N/A
Source
NASDAQ
-
21 Nov 2024 06:30:00 By Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
19 Nov 2024 15:30:00 By Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
04 Nov 2024 06:30:00 By Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
01 Nov 2024 15:45:00 By Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
28 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
12 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2024 05:30:00 By Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
16 Jul 2024 06:30:00 By Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals to Join Russell 3000® Index
13 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
19 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
11 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
31 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
02 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
11 Oct 2023 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >